Total Valuation
Opko Health has a market cap or net worth of CHF935.67M. The enterprise value is $1.12B.
Market CapCHF935.67M
Enterprise Value$1.12B
Share Statistics
Opko Health has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders35.85%
Owned by Institutions8.43%
Financial Efficiency
Opko Health’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -11.32%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-11.32%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee202.50K
Profits Per Employee-75.30K
Employee Count2,997
Asset Turnover0.31
Inventory Turnover7.27
Valuation Ratios
The current PE Ratio of Opko Health is ―. Opko Health’s PEG ratio is -0.01.
PE Ratio―
PS Ratio1.56
PB Ratio0.75
Price to Fair Value0.75
Price to FCF-4.96
Price to Operating Cash Flow-7.11
PEG Ratio-0.01
Income Statement
In the last 12 months, Opko Health had revenue of 606.88M and earned -225.68M in profits. Earnings per share was -0.30.
Revenue606.88M
Gross Profit128.05M
Operating Income-218.99M
Pretax Income-241.39M
Net Income-225.68M
EBITDA-41.30M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was -163.30M and capital expenditures -10.92M, giving a free cash flow of -174.22M billion.
Operating Cash Flow-163.30M
Free Cash Flow-174.22M
Free Cash Flow per Share-10.00T>
Dividends & Yields
Opko Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Opko Health upcoming earnings date is Jul 30, 2026, After Close (Confirmed).
Last Earnings DateApr 28, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Opko Health as a current ratio of 3.97, with Debt / Equity ratio of 32.95%
Current Ratio3.97
Quick Ratio3.52
Debt to Market Cap0.42
Net Debt to EBITDA-1.56
Interest Coverage Ratio-2.02
Taxes
In the past 12 months, Opko Health has paid -15.71M in taxes.
Income Tax-15.71M
Effective Tax Rate0.07
Enterprise Valuation
Opko Health EV to EBITDA ratio is -24.48, with an EV/FCF ratio of -5.30.
EV to Sales1.67
EV to EBITDA-24.48
EV to Free Cash Flow-5.30
EV to Operating Cash Flow-5.66
Balance Sheet
Opko Health has CHF341.88M in cash and marketable securities with CHF396.93M in debt, giving a net cash position of -CHF55.05M billion.
Cash & Marketable SecuritiesCHF341.88M
Total DebtCHF396.93M
Net Cash-CHF55.05M
Net Cash Per Share-CHF10.00T>
Tangible Book Value Per ShareCHF0.36
Margins
Gross margin is 22.73%, with operating margin of -36.08%, and net profit margin of -37.19%.
Gross Margin22.73%
Operating Margin-36.08%
Pretax Margin-39.78%
Net Profit Margin-37.19%
EBITDA Margin-6.81%
EBIT Margin-21.90%
Analyst Forecast
The average price target for Opko Health is CHF2.43, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF2.43
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―